Reproductive and therapeutic cloning, germline therapy, and purchase of gametes and embryos: comments on Canadian legislation governing reproduction technologies.
In Canada, the Assisted Human Reproduction Act received royal assent on 29 March 2004. The approach proposed by the federal government responds to Canadians' strong desire for an enforceable legislative framework in the field of reproduction technologies through criminal law. As a result of the widening gap between the rapid pace of technological change and governing legislation, a distinct need was perceived to create a regulatory framework to guide decisions regarding reproductive technologies. In this article the three main topics covered in the new legislation are commented on: cloning, germline therapy, and purchase of gametes and embryos. Some important issues also covered in the new legislation, such as privacy and access to information, data protection, identity of donors, and inspection, will not be addressed.
Bernier
L
L
Biomedical Ethics Unit, McGill University, 3647 Peel St, Montreal, Canada. louise.bernier@mail.mcgill.ca
Grégoire
D
D
D002170:Canada; D019976:Cloning, Organism / Q000331:legislation & jurisprudence*; D003132:Commerce; D033041:Embryo Research / Q000331:legislation & jurisprudence; D006804:Ergonomics / Q000331:legislation & jurisprudence; D005260:Female; D005854:Germ Cells; D033161:Government Regulation; D006801:Humans; D007883:Legislation, Medical; D008297:Male; D027724:Reproductive Techniques, Assisted / Q000331:legislation & jurisprudence*; D014019:Tissue Donors